Bank of America’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-46,749
| Closed | -$133K | – | 6852 |
|
|
2023
Q1 | $133K | Sell |
46,749
-109,042
| -70% | -$311K | ﹤0.01% | 5344 |
|
|
2022
Q4 | $581K | Sell |
155,791
-8,987
| -5% | -$33.5K | ﹤0.01% | 4591 |
|
|
2022
Q3 | $330K | Sell |
164,778
-10,451
| -6% | -$20.9K | ﹤0.01% | 4920 |
|
|
2022
Q2 | $473K | Buy |
175,229
+45
| +0% | +$121 | ﹤0.01% | 4775 |
|
|
2022
Q1 | $589K | Sell |
175,184
-71,867
| -29% | -$242K | ﹤0.01% | 5016 |
|
|
2021
Q4 | $1.13M | Buy |
247,051
+72,951
| +42% | +$333K | ﹤0.01% | 4417 |
|
|
2021
Q3 | $1.07M | Buy |
+174,100
| New | +$1.07M | ﹤0.01% | 4276 |
|